T-Cell Non-Hodgkin Lymphoma — Trials

T-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

1,008 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 225
Recruiting: 127
Ph III recruiting: 9
Growth YoY: +23.4%
Industry share: 21%
Top sponsor: Institute of Hematology & Blood Diseases Hospital, China
Termination share: 35.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (169)

clinicaltrialsPublishedShowing 1–17 of 17 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06509945	Allo-PBSCT as the First-line Treatment for Patients With the High-risk PTCL	unknown	N/A	50	Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER	1	Aug 1, 2024	clinicaltrials
NCT05904522	Histopathological Changes in Mycosis Fungoides	unknown	N/A	10	Bezmialem Vakif UniversityOTHER	1	Feb 13, 2024	clinicaltrials